CE Program Highlights COVID-19 Treatment Options

Published on 20 May 2020

In response to the COVID-19 outbreak, St. Louis College of Pharmacy is providing continuing pharmacy education (CE) programming for pharmacists and health care professionals who are serving on the front lines of the pandemic.

COVID-19: Treatment Options
CE Hours: 1.00
Release Date: April 20, 2020
Credit Expiration Date: April 20, 2023
Register online at stlcop.edu/ce.

In this webinar, Lindsey Eble, Pharm.D., PGY2 internal medicine pharmacy resident at Barnes-Jewish Hospital, shares information on the latest treatment options for COVID-19 by reviewing the epidemiology, structure and transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), the viral strand that causes COVID-19.

Eble also discusses the most popular treatment options, presents the proposed mechanisms of action, limited in-vitro studies and clinical data on SARS-CoV2, and compares the risks and benefits of different therapeutic options.

Upon completion of the webinar, participants are able to identify potential drug therapies for the treatment of COVID-19 and compare treatment options based on efficacy data, adverse effects and timing.

To learn more about upcoming CE programs, visit stlcop.edu/ce.

Explore more stories in the category of: Pharmacy

Ready to Get Started

We're here to help you take the next step. We can't wait to welcome you to UHSP.